DB11868ExperimentalSmall molecule
Etiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
- Formula / weight
- C8H14N2O2 · 170.212 g/mol (avg)
- Code names
- UCB-6474
Resolves to
Structure
InChIKey
HPHUVLMMVZITSG-UHFFFAOYSA-NSMILESCCC(N1CCCC1=O)C(N)=OWhat you can answer from here — as of March 06, 2025
Which companies are running trials of Etiracetam, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account